A protective role of protease-activated receptor 1 in rat gastric mucosa
Atsufumi Kawabata1, Hiroyuki Nishikawa, Hitomi Saitoh
1School of Pharmaceutical Sciences, Kinki University, Higashi-Osaka, Japan. kawabata@phar.kindai.ac.jp
Protease-activated receptor-1 (PAR-1) activation protects against gastric mucosal injury in rats. This protection is mediated by cyclooxygenase-1 (COX-1) and prostanoids, not sensory neurons.
Area of Science:
- Gastroenterology
- Pharmacology
- Cellular Biology
Background:
- Protease-activated receptor-2 (PAR-2) is known to protect gastric mucosa via sensory neurons.
- The role of protease-activated receptor-1 (PAR-1), a thrombin receptor, in gastric function is unexplored.
- This study investigates PAR-1's potential protective effects on the gastric lining.
Purpose of the Study:
- To determine if a PAR-1 agonist can prevent gastric mucosal damage in a rat model.
- To elucidate the mechanisms underlying PAR-1-mediated gastric protection.
Main Methods:
- Gastric mucosal injury was induced using ethanol/HCl or absolute ethanol in rats.
- Gastric mucosal blood flow and acid secretion were measured.
- Immunohistochemistry was used to detect PAR-1 and cyclooxygenase-1 (COX-1) expression in rat and human gastric tissues.
Main Results:
- The PAR-1 agonist, TFLLR-NH(2), significantly protected against ethanol-induced gastric injury.
- This protective effect was dependent on cyclooxygenase-1 (COX-1) activity, as it was blocked by indomethacin or a COX-1 inhibitor.
- PAR-1 activation increased gastric mucosal blood flow and suppressed acid secretion, independent of sensory neurons.
- PAR-1 and COX-1 were found in the muscularis mucosae and smooth muscle of rat and human stomachs.
Conclusions:
- Systemic PAR-1 activation offers protection against gastric mucosal injury.
- The mechanism involves COX-1-dependent prostanoid formation, impacting gastric blood flow and acid secretion.
- PAR-1 represents a novel target for gastric protection, with a mechanism distinct from PAR-2.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Gastritis II: Pathophysiology


